Protalix BioTherapeutics Revenue (TTM) Analysis

Protalix BioTherapeutics Inc (PLX)

1.31 +0.11 (+9.17%) USD | NYAM | Nov 12, 15:32

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 1999. Upgrade now.

Date	Value
June 30, 2024	38.05M
March 31, 2024	59.65M
December 31, 2023	65.49M
September 30, 2023	63.62M
June 30, 2023	67.46M
March 31, 2023	41.14M
December 31, 2022	47.64M
September 30, 2022	47.57M
June 30, 2022	45.44M
March 31, 2022	43.12M
December 31, 2021	38.35M
September 30, 2021	49.30M
June 30, 2021	48.03M
March 31, 2021	52.57M
December 31, 2020	62.90M
September 30, 2020	61.16M
June 30, 2020	64.62M
March 31, 2020	65.90M
December 31, 2019	54.69M
September 30, 2019	47.29M
June 30, 2019	45.37M
March 31, 2019	37.96M
December 31, 2018	34.24M
September 30, 2018	28.19M
June 30, 2018	23.38M

Date	Value
March 31, 2018	24.90M
December 31, 2017	21.08M
September 30, 2017	18.85M
June 30, 2017	16.00M
March 31, 2017	11.41M
December 31, 2016	9.199M
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015	-5.889M
June 30, 2015	-3.518M
March 31, 2015	-2.168M
December 31, 2014	3.523M
September 30, 2014	3.385M
June 30, 2014	3.037M
March 31, 2014	3.415M
December 31, 2013	0.00
September 30, 2013	10.44M
June 30, 2013	12.47M
March 31, 2013	34.66M
December 31, 2012	34.42M
September 30, 2012	35.06M
June 30, 2012	30.57M
March 31, 2012	6.078M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

38.05M

Minimum

Jun 2024

67.46M

Maximum

Jun 2023

53.51M

Average

52.57M

Median

Mar 2021

Revenue (TTM) Benchmarks